<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of Anginin was assessed in 10 patients with cerebrovascular diseases </plain></SENT>
<SENT sid="1" pm="."><plain>Anginin was administered in daily doses of 1.5 g. during a mean time of 5.25 months </plain></SENT>
<SENT sid="2" pm="."><plain>The duration of follow-up before, during and after treatment was 2 years </plain></SENT>
<SENT sid="3" pm="."><plain>A favourable effect of Anginin was observed on such symptoms as dizziness, disturbances of recent memory, mental fatiguability, difficulties in concentration and <z:hpo ids='HP_0000737'>irritability</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>EEG investigations demonstrated a rise in the index of alpha waves, increased frequency and amplitude of alpha waves, and normalization of tracings in cases with pathological abnormalities </plain></SENT>
<SENT sid="5" pm="."><plain>The basic laboratory investigations failed to reveal any significant changes </plain></SENT>
<SENT sid="6" pm="."><plain>Side effects included transient dyspeptic symptoms were in 5 patients </plain></SENT>
</text></document>